Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alphacaps is a leading German contract development and manufacturing organization (CDMO) specializing in the dietary supplement and nutraceutical sectors. The company provides a comprehensive range of services, from initial formulation development and ingredient sourcing to large-scale manufacturing and specialized packaging. Their production capabilities include a variety of delivery formats, such as hard capsules, tablets, powders, and liquids, tailored to the needs of sports nutrition and wellness brands. Operating out of Augustdorf, Germany, Alphacaps maintains high quality standards with certifications including GMP and IFS Food. Since 2021, the company has operated as part of the CREMER group, leveraging broader logistical and raw material networks to serve its global clientele.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alphacaps.